These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 16642218

  • 1. [Clinical profiles of circulating dendritic cell phenotype and lymphocyte subsets in patients chronically infected with HBV during lamivudine treatment].
    Li HW, Wang HF, Wang FS, Jin B, Duan XZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):43-6. PubMed ID: 16642218
    [Abstract] [Full Text] [Related]

  • 2. [Phenotypes and functions of dendritic cells derived from peripheral blood monocytes of chronic hepatitis B patients with different HBV DNA loads].
    Chen MQ, Shi GF, Lu Q, Li Q, Zhang QH, Qin Q, Weng XH.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):19-23. PubMed ID: 17244453
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of restoration of immune responses of patients with chronic hepatitis B during lamivudine therapy: increased antigen processing and presentation by dendritic cells.
    Akbar SM, Horiike N, Chen S, Michitaka K, Abe M, Hiasa Y, Matsuura B, Onji M.
    J Viral Hepat; 2011 Mar; 18(3):200-5. PubMed ID: 20367796
    [Abstract] [Full Text] [Related]

  • 4. [Clinical research on the treatment effect of autologous dendritic cell vaccine on the patients with chronic hepatitis B].
    Li YG, Chen M, Zhang DZ, Wang ZY, Zeng WQ, Shi XF, Guo Y, Guo SH, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):206-8. PubMed ID: 12716515
    [Abstract] [Full Text] [Related]

  • 5. [Clinical profiles of circulating dendritic cell subsets in chronically HBV-infected patients with interferon-alpha treatment].
    Yan T, Wang HF, Ji W, Zhang AM, Zhang Z, Zhang H, Wang FS.
    Zhonghua Yi Xue Za Zhi; 2005 May 11; 85(17):1177-81. PubMed ID: 16029591
    [Abstract] [Full Text] [Related]

  • 6. [Identification of circulating type II pre-dendritic cells (pDC2) and its clinical significance in chronic hepatitis B virus infection].
    Xing LH, Ma WP, Zhang XS, Shao XW, Ding XL, Peng JY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep 11; 21(3):247-9. PubMed ID: 17971935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.
    J Viral Hepat; 2007 Nov 11; 14(11):767-74. PubMed ID: 17927612
    [Abstract] [Full Text] [Related]

  • 10. [Sequential analyses of circulating HBV specific T helper cell response in chronic hepatitis B patients receiving antiviral treatment].
    Wang M, Zhang LX, Luo SQ, Xu DP, Zhu CL, Tang ZR, Wang FS.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec 11; 19(4):387-90. PubMed ID: 16416002
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
    Yuen MF, Seto WK, Chow DH, Tsui K, Wong DK, Ngai VW, Wong BC, Fung J, Yuen JC, Lai CL.
    Antivir Ther; 2007 Dec 11; 12(8):1295-303. PubMed ID: 18240869
    [Abstract] [Full Text] [Related]

  • 13. [Changes of peripheral plasmacytoid dendritic cells and lymphocyte subsets in chronic hepatitis B patients treated with consensus interferon alpha].
    Zhang AM, Wang HF, Ji W, Zhang Z, Yan T, Zhang H, Wang FS.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar 11; 15(3):184-6. PubMed ID: 17407707
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study on dendritic cells stimulated with HBsAg or HBcAg in patients with chronic hepatitis B].
    Kang P, Luo SL, Li SC.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep 11; 21(3):250-2. PubMed ID: 17971936
    [Abstract] [Full Text] [Related]

  • 15. Significance of alterations in PBMC immunophenotype of children with chronic viral hepatitis C-- the role of dendritic cells.
    Mozer-Lisewska I, Dworacki G, Kaczmarek E, Sluzewski W, Kaczmarek M, Woźniak A, Zeromski J.
    Scand J Immunol; 2006 Apr 11; 63(4):311-9. PubMed ID: 16623932
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
    J Med Virol; 2007 Nov 11; 79(11):1664-70. PubMed ID: 17854034
    [Abstract] [Full Text] [Related]

  • 18. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
    Akarsu M, Sengonul A, Tankurt E, Sayiner AA, Topalak O, Akpinar H, Abacioglu YH.
    J Gastroenterol Hepatol; 2006 Dec 11; 21(12):1783-8. PubMed ID: 17074014
    [Abstract] [Full Text] [Related]

  • 19. [Phenotype and function of myeloid dendritic cells pulsed with hepatitis B virus antigens in patients with HBV-associated hepatocellular carcinoma].
    Qian S, Shi M, Zhang H, Zhang B, Xu DP, Wang FS.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 26; 85(4):248-52. PubMed ID: 15854486
    [Abstract] [Full Text] [Related]

  • 20. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity.
    Kondo Y, Asabe S, Kobayashi K, Shiina M, Niitsuma H, Ueno Y, Kobayashi T, Shimosegawa T.
    J Med Virol; 2004 Nov 26; 74(3):425-33. PubMed ID: 15368520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.